This agreement allows Jubilant access to DiscoveRx PathHunter(TM) and
cAMPHunter(TM) cell lines and proprietary EFC chemiluminescent detection
technology to perform screening on behalf of Jubilant's customers. The
agreement also enables DiscoveRx to expand its platform technology to offer
screening solutions from
DiscoveRx's PathHunter(TM) ss-Arrestin and HitHunter(TM) cAMP assays are homogeneous chemiluminescent assays which are rapidly becoming GPCR screening platform of choice for screening and profiling applications. Jubilant's demonstrated capabilities in discovery research state of the art medicinal chemistry, modeling, structural biology and screening facilities including High Throughput screening facility supported by automated compound management and visualization tools coupled with the DiscoveRx award winning assay platform offers global pharmaceutical companies access to cost effective screening and lead generation services that will enable and accelerate global drug discovery efforts.
Commenting on the Collaboration, Dr.
"We are pleased to announce this agreement with DiscoveRx, and look forward to the prospect of providing value to our customers using DiscoveRx PathHunter(TM) and HitHunter(TM) technologies. This partnership continues to demonstrate Jubilant's mission to partner with leading technology providers that provide access to cutting edge and innovative solutions to accelerate global drug discovery efforts with our collaborators."
"DiscoveRx constantly strives to provide our truly innovative solutions to screening community. We are determined to help expedite the drug discovery processes and are delighted with this relationship with Jubilant. Our customers require an easy access to our innovative product portfolio and such partnerships will add value to our efforts of bringing industry leading portfolio of PathHunter(TM) and HitHunter(TM) GPCR assays to a broader audience."
About DiscoveRx Corporation
Founded in 2000, DiscoveRx is a privately held, venture-backed company
About Jubilant Biosys:
Jubilant Biosys Ltd., a subsidiary of Jubilant Organsys Ltd., provides
integrated drug discovery and development solutions to the global
pharmaceutical industry. Jubilant Biosys has an integrated state of the art
Contacts: DiscoveRx Corporation Sailaja Kuchibhatla Sr. VP Business Development DiscoveRx Corp. firstname.lastname@example.org +1-510-979-1415 ext. 104 Jubilant Biosys Ltd. Esha Kakkar Executive - Corporate Planning Jubilant Biosys Ltd. Ph: +91-80-66628683 email@example.com
SOURCE Jubilant Biosys Ltd